US Patent 11535658 Activatable interleukin-2 polypeptides and methods of use thereof
Patent 11535658 was granted and assigned to Werewolf Therapeutics on December, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 10, 2021
Date of Patent
December 27, 2022
Patent Applicant
Patent Application Number
17523432
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11535658 Activatable interleukin-2 polypeptides and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.